Tulosta

Antikolinergien käyttö virtsankarkailun hoidossa gerasteenisilla, monisairailla ja muistihäiriöisillä iäkkäillä

Lisätietoa aiheesta
19.3.2017
Maria Nuotio

Käytännön ohjeita

Teho

Haittavaikutukset

Haittavaikutusten mekanismi ja lääkkeiden yhteisvaikutuksia

Kirjallisuutta

  1. Kraus SR, Bavendam T, Brake T ym. Vulnerable elderly patients and overactive bladder syndrome. Drugs Aging 2010;27:697-713 «PMID: 20809661»PubMed
  2. Kalder M, Pantazis K, Dinas K ym. Discontinuation of treatment using anticholinergic medications in patients with urinary incontinence. Obstet Gynecol 2014;124:794-800 «PMID: 25198276»PubMed
  3. Wagg A, Arumi D, Herschorn S ym. A pooled analysis of the efficacy of fesoterodine for the treatment of overactive bladder, and the relationship between safety, co-morbidity and polypharmacy in patients aged 65 years or older. Age Ageing 2017 «PMID: 28057620»PubMed
  4. Kay GG, Granville LJ. Antimuscarinic agents: implications and concerns in the management of overactive bladder in the elderly. Clin Ther 2005;27:127-38; quiz 139-40 «PMID: 15763613»PubMed
  5. Kraus SR, Bavendam T, Brake T ym. Vulnerable elderly patients and overactive bladder syndrome. Drugs Aging 2010;27:697-713 «PMID: 20809661»PubMed
  6. Kay GG, Abou-Donia MB, Messer WS Jr ym. Antimuscarinic drugs for overactive bladder and their potential effects on cognitive function in older patients. J Am Geriatr Soc 2005;53:2195-201 «PMID: 16398909»PubMed
  7. Popescu BO, Toescu EC, Popescu LM ym. Blood-brain barrier alterations in ageing and dementia. J Neurol Sci 2009;283:99-106 «PMID: 19264328»PubMed
  8. Paquette A, Gou P, Tannenbaum C. Systematic review and meta-analysis: do clinical trials testing antimuscarinic agents for overactive bladder adequately measure central nervous system adverse events? J Am Geriatr Soc 2011;59:1332-9 «PMID: 21718264»PubMed
  9. Wagg A, Khullar V, Marschall-Kehrel D ym. Flexible-dose fesoterodine in elderly adults with overactive bladder: results of the randomized, double-blind, placebo-controlled study of fesoterodine in an aging population trial. J Am Geriatr Soc 2013;61:185-93 «PMID: 23350833»PubMed
  10. Dubeau CE, Kraus SR, Griebling TL ym. Effect of fesoterodine in vulnerable elderly subjects with urgency incontinence: a double-blind, placebo controlled trial. J Urol 2014;191:395-404 «PMID: 23973522»PubMed
  11. Gill SS, Mamdani M, Naglie G ym. A prescribing cascade involving cholinesterase inhibitors and anticholinergic drugs. Arch Intern Med 2005;165:808-13 «PMID: 15824303»PubMed
  12. Sink KM, Thomas J 3rd, Xu H ym. Dual use of bladder anticholinergics and cholinesterase inhibitors: long-term functional and cognitive outcomes. J Am Geriatr Soc 2008;56:847-53 «PMID: 18384584»PubMed
  13. Isik AT, Celik T, Bozoglu E ym. Trospium and cognition in patients with late onset Alzheimer disease. J Nutr Health Aging 2009;13:672-6 «PMID: 19657549»PubMed
  14. Hashimoto M, Imamura T, Tanimukai S ym. Urinary incontinence: an unrecognised adverse effect with donepezil. Lancet 2000;356:568 «PMID: 10950240»PubMed
  15. Carrière I, Fourrier-Reglat A, Dartigues JF ym. Drugs with anticholinergic properties, cognitive decline, and dementia in an elderly general population: the 3-city study. Arch Intern Med 2009;169:1317-24 «PMID: 19636034»PubMed
  16. Lampela P, Taipale H, Hartikainen S. Use of Cholinesterase Inhibitors Increases Initiation of Urinary Anticholinergics in Persons with Alzheimer's Disease. J Am Geriatr Soc 2016;64:1510-2 «PMID: 27401848»PubMed
  17. Jessen F, Kaduszkiewicz H, Daerr M ym. Anticholinergic drug use and risk for dementia: target for dementia prevention. Eur Arch Psychiatry Clin Neurosci 2010;260 Suppl 2:S111-5 «PMID: 20960005»PubMed
  18. Gray SL, Anderson ML, Dublin S ym. Cumulative use of strong anticholinergics and incident dementia: a prospective cohort study. JAMA Intern Med 2015;175:401-7 «PMID: 25621434»PubMed
  19. Boudreau DM, Yu O, Gray SL ym. Concomitant use of cholinesterase inhibitors and anticholinergics: prevalence and outcomes. J Am Geriatr Soc 2011;59:2069-76 «PMID: 22091958»PubMed
  20. Samuelsson E, Odeberg J, Stenzelius K ym. Effect of pharmacological treatment for urinary incontinence in the elderly and frail elderly: A systematic review. Geriatr Gerontol Int 2015;15:521-34 «PMID: 25656412»PubMed
Käypä hoito -suositukset ovat riippumattomia, tutkimusnäyttöön perustuvia kansallisia hoitosuosituksia. Lue lisää
KÄYPÄ HOITO -SUOSITUS Virtsankarkailu (naiset)
LINKKIEN TYYPIT JA VÄRIKOODIT
Kirjallisuusviite
Kuva
Linkki toiselle sivustolle
Lisätietoa
Näytönastekatsaus
PDF-tiedosto
PubMed-abstrakti
Taulukko